The results showed that DSCC1 was altered in 17% of liver hepatocellular carcinoma samples and 5% of lung adenocarcinoma samples, indicating the role of genetic alterations in the dysregulation of DSCC1 [8,25]. This evidence concerns the gene DSCC1 and lung adenocarcinoma.